The effects of Alcoholics Anonymous on women returning from prison
The effects of alcohol abuse, as well as recovery from it, have been intensely studied. However, incarcerated women have remained an extremely understudied population despite steadily increasing in recent decades. One of the main ways to help individuals (as well as prisoners) with their recovery is through a 12-step program like Alcoholics Anonymous (AA).
A new study released in the March 2011 issue of Alcoholism: Clinical & Experimental Research, which is currently available at Early View, explores that subject in detail and found that AA attendance of at least once per week greatly increased the chance of a positive outcome.
According to Yael Chatav Schonbrun, a researcher in Butler Hospital at Brown University, this research is only the first step to help a population at risk of mental health disorders, risky sexual behavior and physical health problems.
"Despite the recent growth in this population, and despite the public health problems encountered, incarcerated women remain understudied. It is clear that AA is a widely available and familiar resource for underserved populations, and so it was logical to examine predictors of AA attendance, and how useful it would be for incarcerated women," he said.
The researchers recruited 223 hazardously-drinking women (averaged around 12 drinks per drinking day) from the women's facility at the Rhode Island Department of Corrections Adult Correctional Institute and ran two sessions one during incarceration and one after release along with a one-, three- and six-month follow-up to determine alcohol and treatment use. During the sessions, a timeline method was used to assess the alcohol use of the participants in the previous 90 days, as well as determining the severity of their involvement with alcohol, exposure to other drugs and participation in AA.
The data showed that if the women attended AA once a week or more, there was a significant decrease in the levels of alcohol-related consequences, and an overall decrease in the total days spent drinking.
This research is the first of its kind to evaluate AA attendance and alcohol-related outcomes among incarcerated hazardously-drinking women returning to the community. According to Schonbrun, "given that AA is so widely available, and is a familiar resource among incarcerated women, finding a method to increase utilization of AA might have great utility for improving alcohol and alcohol-related outcomes for incarcerated women."
However, future research is still required to answer questions regarding the duration and frequency of AA attendance needed for positive results, as well as evaluating if incarcerated men behave in a similar way.
"We hope that this study will call further attention to the needs of incarcerated women," said Schonbrun, "and that this research will help to arouse increased interest in addressing the needs of this underserved population."
Provided by Alcoholism: Clinical & Experimental Research
-
New nanostructure for batteries keeps going and going,
28 comments
-
Penn astrophysicists zero in on gravity theory,
204 comments
-
Engineer thinks we could build a real starship enterprise in 20 years,
49 comments
-
Sugar makes you stupid: Study shows high-fructose diet sabotages learning, memory,
13 comments
-
Brain oscillations reveal that our senses do not experience the world continuously,
10 comments
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Raising HDL not a sure route to countering heart disease
A new paper published online in The Lancet challenges the assumption that raising a person's HDL the so-called "good cholesterol" will necessarily lower the risk of a heart attack. The new research underscores the va ...
Medicine & Health / Cardiology
24 minutes ago |
not rated yet |
0
|
Meta-analysis confirms benefit of statins in those with no previous history of vascular disease
Statin therapy safely reduces the risk of major vascular events (non-fatal heart attacks, strokes, and revascularisation surgery) by about a fifth in a wide range of individuals, including those with no previous history of ...
Medicine & Health / Cardiology
24 minutes ago |
not rated yet |
0
Many parents of kids with autism don't put faith in pediatricians
(HealthDay) -- Many parents of children with an autism spectrum disorder don't feel they can turn to their pediatricians for advice on treatments, a new study finds.
Medicine & Health / Autism spectrum disorders
1 hour ago |
not rated yet |
0
Pancreatic islets infusion for diabetes patient being readied for procedure in Japan
The Japanese Pancreas and Islet Transplantation Association (JPITA) is preparing for the nation's first transplantation of pancreatic islets from a brain-dead donor to a patient with Type 1 diabetes, it was learned Saturday.
4 minutes ago |
not rated yet |
0
Hormone-depleting drug shows promise against localized high-risk prostate tumors
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, ...
54 minutes ago |
not rated yet |
0
T-ray madness: Scientists score wireless data record
(Phys.org) -- Wednesday headlines trumpeted how "Japanese researchers smash Wi-Fi records" and "Scientists show off the future of Wi-Fi." The excitement is for good reason. A team of scientists have broken ...
Clean energy becomes a selling point
As somewhat bewildered Apple shoppers in San Francisco, New York and Toronto learned firsthand this month, Greenpeace has a new enemy: dirty data. To attract attention to its report, "How Clean Is My Cloud?" - which draws ...
Revised glioblastoma classification should improve patient care
Radiation oncology researchers have revised the system used by doctors since the 1990s to determine the prognosis of people with glioblastoma, which is the most devastating of malignant brain tumors.
Experimental agent may help older people with chronic leukemia
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial.
Phase I study of temsirolimus, capecitabine proves safe; positive survival trend seen
A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients. In addition, the Georgetown Lombardi Comprehensive ...
Study combines lapatinib with cetuximab to overcome resistance in EGFR-driven tumors
Targeted therapies have been studied for years, but recent laboratory research is providing robust clues about drugs that might work better in combination, particularly in treating cancers that have become resistant to therapy. ...